HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins

Journal of Cellular Biochemistry

Volumn 113, Issue 6, 2012, Pages 2167-2177

  Jung, Kwang Hwa ^a   Noh, Ji Heon ^a   Kim, Jeong Kyu ^a   Eun, Jung Woo ^a   Bae, Hyun Jin ^a   Xie, Hong Jian ^a   Chang, Young Gyoon ^a   Kim, Min Gyu ^a   Park, Hanna ^a   Lee, Jung Young ^a   Nam, Suk Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

APOPTOSIS; CELL CYCLE; HDAC2; LUNG CANCER; p21WAF1 CIP1

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; CYCLIN E2; HISTONE DEACETYLASE 2; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 2; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84859565614     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24090     Document Type: Article

References (26)

1. Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang L, Powell CA,. 2003. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 163: 1949-1960.
2. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T,. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601.
3. Fernandes I, Bastien Y, Wai T, Nygard K, Lin R, Cormier O, Lee HS, Eng F, Bertos NR, Pelletier N, Mader S, Han VK, Yang XJ, White JH,. 2003. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell 11: 139-150.
4. Fritsche P, Seidler B, Schuler S, Schnieke A, Gottlicher M, Schmid RM, Saur D, Schneider G,. 2009. HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA. Gut 58: 1399-1409.
5. Glozak MA, Seto E,. 2007. Histone deacetylases and cancer. Oncogene 26: 5420-5432.
6. Gregoretti IV, Lee YM, Goodson HV,. 2004. Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis. J Mol Biol 338: 17-31.
7. Huang BH, Laban M, Leung CH, Lee L, Lee CK, Salto-Tellez M, Raju GC, Hooi SC,. 2005. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ 12: 395-404.
8. Johnstone RW,. 2002. Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat Rev Drug Discov 1: 287-299.
9. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP,. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
10. Kortenhorst MS, Carducci MA, Shabbeer S,. 2006. Acetylation and histone deacetylase inhibitors in cancer. Cell Oncol 28: 191-222.
11. Luo J, Su F, Chen D, Shiloh A, Gu W,. 2000. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381.
12. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK,. 2001a. Histone deacetylases and cancer: Causes and therapies. Nat Rev Cancer 1: 194-202.
13. Marks PA, Richon VM, Breslow R, Rifkind RA,. 2001b. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 13: 477-483.
14. Minucci S, Pelicci PG,. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6: 38-51.
15. Noh JH, Eun JW, Ryu SY, Jeong KW, Kim JK, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW,. 2006. Increased Expression of Histone Deacetylase2 is Found in Human Hepatocellular Carconoma. Mol Cell Toxicol 2: 166-169.
16. Osada H, Tatematsu Y, Saito H, Yatabe Y, Mitsudomi T, Takahashi T,. 2004. Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer 112: 26-32.
17. Shah L, Walter KL, Borczuk AC, Kawut SM, Sonett JR, Gorenstein LA, Ginsburg ME, Steinglass KM, Powell CA,. 2004. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma. Cancer 101: 1632-1638.
18. Song J, Clair T, Noh JH, Eun JW, Ryu SY, Lee SN, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW,. 2005a. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate. Biochem Biophys Res Commun 337: 967-975.
19. Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW,. 2005b. Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 113: 264-268.
20. Taunton J, Hassig CA, Schreiber SL,. 1996. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272: 408-411.
21. Weichert W,. 2009. HDAC expression and clinical prognosis in human malignancies. Cancer Lett 280: 168-176.
22. Witt O, Deubzer HE, Milde T, Oehme I,. 2009. HDAC family: What are the cancer relevant targets? Cancer Lett 277: 8-21.
23. Yang XJ, Seto E,. 2007. HATs and HDACs: From structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26: 5310-5318.
24. Yarden RI, Brody LC,. 1999. BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci USA 96: 4983-4988.
25. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D,. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13: 1924-1935.
26. Zhu P, Martin E, Mengwasser J, Schlag P, Janssen KP, Gottlicher M,. 2004. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5: 455-463.